AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

Recruitingn/aAges 22 Years - anyAllEMVision Medical Devices Ltd
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this research is to evaluate a new investigational device for the diagnosis of stroke, the EMVision emu™ Brain Scanner. Stroke is the result of a blood clot stopping the normal flow of blood in the brain (ischaemic stroke) or a breakage in a blood vessel causing bleeding in the brain (haemorrhagic stroke). Stroke is a medical emergency and must be quickly diagnosed and treated. Computed tomography (CT) or magnetic resonance imaging (MRI) scans are commonly used to diagnose stroke, but they are not always readily available. EMVision has developed the emu™ Brain Scanner, a helmet-like device which scans the head using ultra-high frequency radio signals. It is portable and easy to use, making it more accessible than CT or MRI machines. Easier access to the EMVision emu™ Brain Scanner may reduce the time taken to diagnose stroke, leading to faster treatment and better health

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Adults ≥22 years of age 2. Observable acute neurological deficit suspected to be stroke and within 24 hours of symptom onset 3. The use of the EMVision emu™ Brain Scanner will not delay the treatment of the patient 4. CT or MRI brain imaging following clinical evaluation per standard of care 5. Head size deemed suitable for scanning with the EMVision emu™ Brain Scanner - Exclusion Criteria: 1. Has received treatment for current (suspected) stroke event prior to initial CT/MRI scan OR EMVision emu™ Brain Scanner scan (such as thrombolysis) 2. In-patient for a neurological condition prior to suspected stroke onset 3. In-patient in intensive care unit prior to suspected stroke onset 4. Contraindication to neuroimaging, such as a contrast allergy or other condition that prohibits CT, MRI and/or angiography 5. Presence of any implanted electro-stimulating devices in the head and neck 6. Presence of any metallic implants in the cranial vault or surrounding bones/tissue (Note that metallic objects distant from the scan area, such as dental implants, nasal piercing etc., are acceptable) 7. Presence of an intracranial pressure monitor or any other similar sensor that may compromise the placement of the investigational device 8. Inability to wear the investigational device (skin lesions on scalp, obvious recent blunt or penetrating injury to head, previous intracranial surgeries, neck injury etc.) 9. Unable to lie still for the duration of the scan 10. Pregnant or breastfeeding 11. Any other condition or symptoms preventing the participant from entering the study, according to the investigator´s judgment -
💊

What it tests

  • Brain Scan
📍

Where

8 sites
UCLA
Los Angeles, United States
Mayo Jacksonville
Jacksonville, United States
Mount Sinai West
New York, United States
Mount Sinai Health System
New York, United States
Memorial Hermann Memorial City Medical Center
Houston, United States
UTHealth
Houston, United States
Liverpool Hospital
Liverpool, Australia
Royal Melbourne Hospital
Parkville, Australia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy